Angelini Pharma Espaa A Is A Subsidiary Of Angelini Pharmapart Of Angelini Industriesfocusing On Brain Healthophthalmologyinfectious Diseasesand Consumer Healthcarethe Company Has Established A Significant Presence In Spain Since Acquiring Farma Lepori In 1978Contributing To Its Global Reach In The Pharmaceutical Sector The Company Offers A Variety Of Pharmaceutical Productsincluding Prescription And Over The Counter Medications For Pain And Inflammation Disordersmental Healthand Central Nervous System Diseasesnotable Products Include Benzydaminetrazodoneparacetamoland Prulifloxacinmarketed Under Brands Like Andolextritticoand Tachipirinaangelini Pharma Espaa A Serves A Diverse Customer Baseincluding Hospitalsresearch Centersand Pharma Biotech Companiesand Engages In Strategic Partnerships To Enhance Its Market Presence With Nearly 200 Employees And A Turnover Exceeding 84 Million Euros As Of 2022Angelini Pharma Espaa A Is Committed To Providing Innovative Healthcare Solutions And Improving Patient Outcomes In The Spanish Healthcare Landscape
